AbbVie Inc
(XSGO:ABBVCL)
CLP
171,590
(0%)
Market Cap: 436.39 Tn
Enterprise Value: 497.05 Tn
PE Ratio: 72.63
PB Ratio: 0
GF Score: 76/100 AbbVie Inc. at Morgan Stanley Global Healthcare Conference Transcript
Sep 15, 2026 / 02:00PM GMT
Terence Flynn
Morgan Stanley - Analyst
All right. Great. Thanks for joining us, everybody. I'm Terence Flynn, Morgan Stanley's US biopharma analyst. Very pleased to be hosting AbbVie.
For important disclosures, please see Morgan Stanley's research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
As I mentioned, very pleased to be hosting AbbVie this morning. We have Rob Michael, the company's Chairman of the Board and CEO. We have Jeff Stewart, the company's EVP, Chief Commercial Officer; and Roopal Thakkar, the company's Head of R&D and Chief Scientific Officer. Thank you all three of you for joining me today. Really appreciate it.
Robert Michael
AbbVie Inc. - Chairman of the Board & Chief Executive Office
Great to be here.
Questions & Answers
Terence Flynn
Morgan Stanley - Analyst
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot